- £4.84bn
 - £5.76bn
 - $2.29bn
 
- 82
 - 26
 - 60
 - 58
 
Annual balance sheet for ConvaTec, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 565 | 463 | 144 | 97.6 | 64.7 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 290 | 302 | 339 | 325 | 318 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,179 | 1,111 | 889 | 870 | 793 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 438 | 450 | 480 | 549 | 570 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,767 | 3,674 | 3,592 | 3,714 | 3,515 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 513 | 569 | 533 | 536 | 512 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,096 | 1,979 | 1,982 | 2,021 | 1,826 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,671 | 1,695 | 1,610 | 1,693 | 1,689 | 
| Total Liabilities & Shareholders' Equity | 3,767 | 3,674 | 3,592 | 3,714 | 3,515 | 
| Total Common Shares Outstanding |